Valuation: Terumo Corporation

Market Cap 3,301B 21.03B 18.34B 17.32B 15.72B 29.46B 2,018B 29.58B 207B 80.04B 1,026B 79B 77.25B P/E 2027 *
17x
P/E 2028 * 17.2x
Enterprise Value 3,342B 21.29B 18.56B 17.53B 15.92B 29.82B 2,043B 29.95B 210B 81.02B 1,039B 79.97B 78.19B EV / Sales 2027 *
2.65x
EV / Sales 2028 * 2.45x
Free-Float
97.07%
Yield 2027 *
1.66%
Yield 2028 * 1.81%
1 day-2.33%
1 week-0.36%
Current month-11.05%
1 month-9.47%
3 months+0.61%
6 months+9.76%
Current year-1.41%
1 week 2,228.5
Extreme 2228.5
2,313.5
1 month 2,194.5
Extreme 2194.5
2,645.5
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-0.36%-8.97%+3.49% 21.03B
+0.37%+0.65%-24.57%+1.93% 178B
-0.69%+1.29%-3.10%+11.50% 118B
-0.20%-3.98%+6.47%+71.79% 58.92B
-0.24%+1.74%-3.26%-31.97% 49.29B
-0.22%-0.37%+10.27%+40.45% 48.17B
+1.61%+7.61%+32.47%-5.11% 33.72B
-1.49%-2.74% - - 27.76B
-1.17%+4.64%+42.17%-7.72% 25.5B
+1.02%+5.99%+6.51%-15.81% 22.1B
Average -0.33%+1.63%+6.44%+7.62% 58.19B
Weighted average by Cap. -0.16%+0.98%-3.41%+10.21%

Financials

2027 *2028 *
Net sales 1,259B 8.02B 6.99B 6.6B 6B 11.23B 770B 11.28B 79.1B 30.52B 391B 30.13B 29.46B 1,339B 8.53B 7.44B 7.02B 6.38B 11.95B 819B 12B 84.15B 32.47B 416B 32.05B 31.34B
Net income 192B 1.22B 1.07B 1.01B 913M 1.71B 117B 1.72B 12.05B 4.65B 59.59B 4.59B 4.49B 192B 1.22B 1.07B 1.01B 915M 1.71B 117B 1.72B 12.07B 4.66B 59.7B 4.6B 4.5B
Net Debt 40.36B 257M 224M 212M 192M 360M 24.67B 362M 2.54B 979M 12.54B 966M 944M -26.39B -168M -147M -138M -126M -236M -16.13B -237M -1.66B -640M -8.2B -632M -618M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
18/09/26 JPY 2,238.00 -2.33% 6,326,500
17/09/26 JPY 2,291.50 +2.12% 3,177,500
16/09/26 JPY 2,244.00 +0.07% 2,879,300
15/09/26 JPY 2,242.50 -0.88% 2,588,100
14/09/26 JPY 2,262.50 +0.73% 6,110,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,238.00JPY
Average target price
3,110.00JPY
Spread / Average Target
+38.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!